16 C
gurgaon
Wednesday, October 28, 2020
video

Alembic Pharmaceuticals receives USFDA Approval for Pramipexole Dihydrochloride

Extended-Release Tablets, 0.375 mg, 0.75 mg, 1.5 mg, 2.25 mg, 3 mg, 3.75 mg, and 4.5 mg. Alembic Pharmaceuticals Limited today announced that the Company has...

US FDA ACCEPTS REGULATORY SUBMISSIONS FOR REVIEW OF TAFAMIDIS

FDA GRANTS A PRIORITY REVIEW BASED ON PHASE 3 ATTR-ACT STUDY FINDINGS IN ATTR-CM Pfizer Inc. (NYSE: PFE) announced today that the US Food and...

Glenmark Pharmaceuticals Announces Entry into Branded Dermatology

Glenmark’s branded portfolio for the US market will be developed and commercialized by Glenmark Therapeutics Inc., USA, a wholly owned subsidiary of Glenmark Holding,...

Zydus receives final approval from the USFDA for Acetazolamide ER Capsules

Zydus Cadila has received the final approval from the USFDA to market Acetazolamide ER Capsules (US RLD – Diamox). It will be manufactured at...

LupinLife’s Corcal Bone & Beauty to launch at Lakme Fashion Week

Mumbai, January 18, 2019: LupinLife’s Corcal Bone & Beauty announces a collaboration with Lakme Fashion Week to celebrate #beautifullystrong women across India at the upcoming Lakme Fashion Week Summer/Resort...

Aurobindo Pharma receives USFDA Approval for Potassium Chloride ER Tablets

Aurobindo Pharma Limited is pleased to announce that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture...

Biosimilar Trastuzumab Co-Developed by Biocon Receives Approval in the EU

Ogivri®, a bio-similar Trastuzumab jointly developed by Bio-con and Mylan, has been approved in the EU. The European Commission has granted Marketing Authorization for...

Zydus receives tentative approval from the USFDA for Esomeprazole Magnesium Delayed-Release Capsules USP

Zydus Cadila has received the tentative approval from the USFDA to market Esomeprazole Magnesium Delayed-Release Capsules (US RLD – NEXIUM). It will be manufactured...

Lupin receives FDA approval for Levothyroxine Sodium Tablets USP

Mumbai, Baltimore, January 21, 2019: Pharma major Lupin announced that it has received approval for its Levothyroxine Sodium Tablets USP, 25 mcg, 50 mcg,...

Aurobindo Pharma’s subsidiary Acrotech Biopharma to acquire portfolio of seven marketed oncology injectable products

Acquisition for an upfront purchase price of $160 million in cash plus up to $140 million on achieving regulatory and sales-based milestones  Acquired portfolio includes...

Recent Posts